Skip to content
healthcare.dev

signature care clearlax

NDC 21130-847, Polyethylene Glycol 3350, powder, for solution, from Safeway.

Product NDC
21130-847
Status
Listed
Labeler
Safeway
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090685
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/21130-847 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
21130-847-0121130084701119 g in 1 BOTTLE (21130-847-01)
21130-847-0221130084702238 g in 1 BOTTLE (21130-847-02)
21130-847-0321130084703510 g in 1 BOTTLE (21130-847-03)
21130-847-0921130084709765 g in 1 BOTTLE (21130-847-09)
21130-847-522113008475210 PACKET in 1 CARTON (21130-847-52) / 17 g in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 21130-847 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/21130-847 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 21130-847. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.